靶点针对疾病信息22(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Opioid receptor delta (OPRD1)
INDICATI
Approved Bowel habit change [ICD-11: ME05]
INDICATI
Approved Chronic pain [ICD-11: MG30]
INDICATI
Approved Cough [ICD-11: MD12]
INDICATI
Approved Irritable bowel syndrome [ICD-11: DD91]
INDICATI
Approved Pain [ICD-11: MG30-MG3Z]
INDICATI
Approved Spinal pain [ICD-11: ME84]
INDICATI
Phase 2 Anxiety disorder [ICD-11: 6B00-6B0Z]
INDICATI
Phase 1 Coronary vasospastic disease [ICD-11: BA85]
INDICATI
Phase 1 Functional bladder disorder [ICD-11: GC50]
INDICATI
Phase 1 Migraine [ICD-11: 8A80]
INDICATI
Phase 1 Opioid use disorder [ICD-11: 6C43]
INDICATI
Discontinued in Phase 1 Unspecific substance use disorder [ICD-11: 6C4Z]
INDICATI
Preclinical Obesity [ICD-11: 5B80-5B81]
INDICATI
Preclinical Substance abuse [ICD-11: 6C40]
INDICATI
Investigative Abnormal micturition [ICD-11: MF50]
INDICATI
Investigative Bladder disorder [ICD-11: GC01]
INDICATI
Investigative Depression [ICD-11: 6A70-6A7Z]